BioSpace News Archive

Therapix Biosciences Ltd. (Nasdaq: TRPX) issued today a letter to its shareholders, from the CEO and chairman of the company.

Ohio-based retail drug store chain will invest in pharmacy automation to boost efficiency, lower costs and provide exemplary patient care

-- CARB-X funding of up to $3.5 million highlights MicrobeDx innovative system for rapid microbial detection and antimicrobial susceptibility testing --

New business model delivers fresh products in as little as three days.

Alcyone Lifesciences, Inc., a leader in disease modifying therapies for the central nervous system (CNS) through its Advanced Precision Delivery Platforms, announced a presentation on its intrathecal delivery technology platform that has the potential to impact several CNS gene therapies and their development.

GOLO, LLC Announces Results of a Study Measuring the Effect of the GOLO Diet and ReleaseTM Supplement on Weight, Glycemic Control and Indicators of Insulin Sensitivity in Overweight and Obese Patients with Type 2 Diabetes.

Bayer announced today that clinical data from its pulmonary disease franchise will be presented in scientific sessions at the 2018 American Thoracic Society (ATS) International Conference, May 18-23rd in San Diego, CA.

The survey results also show rising concerns about managing risk and proving compliance

PulsePoint, today announced the launch of Genome by PulsePoint™

Therapeutic soft lens designed to deliver pain and anti-infection drugs more evenly over time - replacing messy, less effective drops